244 related articles for article (PubMed ID: 24428792)
21. [Retinopathy of prematurity - therapy. Part 2].
Prepiaková Z; Tomčíková D; Kostolná B; Gerinec A
Cesk Slov Oftalmol; 2014 Apr; 70(2):50-4. PubMed ID: 25030312
[TBL] [Abstract][Full Text] [Related]
22. Successful Surgical Management of Retinopathy of Prematurity Showing Rapid Progression despite Extensive Retinal Photocoagulation.
Gadkari SS; Kulkarni SR; Kamdar RR; Deshpande M
Middle East Afr J Ophthalmol; 2015; 22(3):393-5. PubMed ID: 26180484
[TBL] [Abstract][Full Text] [Related]
23. Systemic Solutions in Retinopathy of Prematurity.
Moshfeghi DM
Am J Ophthalmol; 2018 Sep; 193():xiv-xviii. PubMed ID: 29792838
[TBL] [Abstract][Full Text] [Related]
24. Bevacizumab for retinopathy of prematurity.
Reynolds JD
N Engl J Med; 2011 Feb; 364(7):677-8. PubMed ID: 21323546
[No Abstract] [Full Text] [Related]
25. Efficacy of intravitreal injection of anti-vascular endothelial growth factor agents for stage 4 retinopathy of prematurity.
Cheng HC; Lee SM; Hsieh YT; Lin PK
Retina; 2015 Apr; 35(4):660-6. PubMed ID: 25313709
[TBL] [Abstract][Full Text] [Related]
26. Dramatic regression of persistent tunica vasculosa lentis associated with retinopathy of prematurity following treatment with intravitreal bevacizumab.
Goldman DR; Baumal CR
J Pediatr Ophthalmol Strabismus; 2013 Jun; 50 Online():e27-9. PubMed ID: 24601434
[TBL] [Abstract][Full Text] [Related]
27. Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab.
Ittiara S; Blair MP; Shapiro MJ; Lichtenstein SJ
J AAPOS; 2013 Jun; 17(3):323-5. PubMed ID: 23607977
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.
Axer-Siegel R; Snir M; Ron Y; Friling R; Sirota L; Weinberger D
Retina; 2011; 31(7):1239-47. PubMed ID: 21555969
[TBL] [Abstract][Full Text] [Related]
29. Different refractive errors in triplets with retinopathy of prematurity treated with bevacizumab.
Tseng CC; Chen SN; Hwang JF; Lin CJ
J Pediatr Ophthalmol Strabismus; 2012 Aug; 49 Online():e41-3. PubMed ID: 22881829
[TBL] [Abstract][Full Text] [Related]
30. OUTCOMES OF NONCONFLUENT DIODE LASER PANRETINAL PHOTOCOAGULATION FOR AGGRESSIVE POSTERIOR RETINOPATHY OF PREMATURITY AFTER INTRAVITREAL BEVACIZUMAB.
Mammo DA; Rubino SM; Quiram PA
Retina; 2021 Apr; 41(4):706-710. PubMed ID: 32796444
[TBL] [Abstract][Full Text] [Related]
31. Fluorescein angiography of aggressive posterior retinopathy of prematurity treated with intravitreal anti-VEGF in large preterm babies.
Park SW; Jung HH; Heo H
Acta Ophthalmol; 2014 Dec; 92(8):810-3. PubMed ID: 24909062
[No Abstract] [Full Text] [Related]
32. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.
Chung EJ; Kim JH; Ahn HS; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1727-30. PubMed ID: 17690897
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal bevacizumab for retinopathy of prematurity: refractive error results.
Harder BC; Schlichtenbrede FC; von Baltz S; Jendritza W; Jendritza B; Jonas JB
Am J Ophthalmol; 2013 Jun; 155(6):1119-1124.e1. PubMed ID: 23490192
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.
Mintz-Hittner HA; Kennedy KA; Chuang AZ;
N Engl J Med; 2011 Feb; 364(7):603-15. PubMed ID: 21323540
[TBL] [Abstract][Full Text] [Related]
35. Present-day conservative treatment retinopathy of prematurity.
Monika M; Katarzyna KK; Leszek K
Klin Oczna; 2013; 115(1):65-8. PubMed ID: 23882745
[TBL] [Abstract][Full Text] [Related]
36. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
Kychenthal A; Dorta P
Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
[TBL] [Abstract][Full Text] [Related]
37. An evidence-based meta-analysis of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 1. Retinopathy of prematurity.
Mititelu M; Chaudhary KM; Lieberman RM
J Pediatr Ophthalmol Strabismus; 2012; 49(6):332-40. PubMed ID: 22938516
[TBL] [Abstract][Full Text] [Related]
38. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).
Dorta P; Kychenthal A
Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475
[TBL] [Abstract][Full Text] [Related]
39. Reactivation of retinopathy of prematurity after bevacizumab injection.
Hu J; Blair MP; Shapiro MJ; Lichtenstein SJ; Galasso JM; Kapur R
Arch Ophthalmol; 2012 Aug; 130(8):1000-6. PubMed ID: 22491394
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal anti-VEGF therapy as a treatment for retinopathy of prematurity: what we know after 7 years.
Klufas MA; Chan RV
J Pediatr Ophthalmol Strabismus; 2015; 52(2):77-84. PubMed ID: 25798707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
